Blood and Tissue Protozoal Infections – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103

Blood and Tissue Protozoal Infections

Pharmaceutical Microbiology • Source Session/Topic 37
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 37: Blood and Tissue Protozoal Infections

Total Session Time: 120 minutes

Pre-requisites

• Human anatomy and physiology

Students Learning Tasks

By the end of this session students are expected to be able to:

• Describe causative agents, transmission, life cycle, signs/symptoms of

Malaria, Toxoplamosis andTrypanosomiasis

Resources Needed:

• Flip charts, marker pens, and masking tape
• Black/white board and chalk/whiteboard markers

SESSION OVERVIEW

|Step |Time |Activity/ |Content |

| | |Method | |

|1 |5 minutes |Presentation |Introduction, Learning Tasks |

|2 | |Small group |Malaria |

| |40 minutes |discussion/ | |

| | |Presentation | |

|3 | 35 |Presentation |Toxoplasmosis |

| |minutes | | |

|4 |30 minutes |Presentation |African Trypanosomiasis |

|5 |5 minutes |Presentation |Key Points |

| 6|5 minutes |Presentation |Evaluation |

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing

STEP 2: Malaria (40 minutes)

Cause and Transmission

• Malaria is a life-threatening mosquito-borne blood disease caused by

various species of Plasmodium

• Species of Plasmodium causing malaria include:

o Plasmodium falciparum

o Plasmodium vivax

o Plasmodium ovale

o Plasmodium malariae

o Plasmodium knowlesi

• Severity of malaria depends on the species involved
• Malaria is transmitted by the bite of an infected female Anopheles

mosquito.

• Life cycle of Plasmodium

o The malaria parasite life cycle involves two hosts.

o During a blood meal, a malaria-infected female Anopheles mosquito

inoculates sporozoites into the human host

o Sporozoites infect liver cells and mature into schizonts, which

rupture and release (merozoites (In P. vivax and P. ovale a dormant

stage (hypnozoites) can persist in the liver and cause relapses by

invading the bloodstream weeks, or even years later.)

o After this initial replication in the liver (exo-erythrocytic

schizogony), the parasites undergo asexual multiplication in the

erythrocytes (erythrocytic schizogony).

o Merozoites infect red blood cells.

o The ring stage trophozoites mature into schizonts, which rupture

releasing merozoites

o Some parasites differentiate into sexual erythrocytic stages

(gametocytes)

o Blood stage parasites are responsible for the clinical

manifestations of the disease. The gametocytes, male

(microgametocytes) and female (macrogametocytes), are ingested by an

Anopheles mosquito during a blood meal

o The parasites’ multiplication in the mosquito is known as the

sporogonic cycle

o While in the mosquito’s stomach, the microgametes penetrate the

macrogametes generating zygotes

o The zygotes in turn become motile and elongated (ookinetes) which

invade the midgut wall of the mosquito where they develop into

oocysts

o The oocysts grow, rupture, and release sporozoites, which make their

way to the mosquito’s salivary glands. Inoculation of the

sporozoites into a new human host perpetuates the malaria life

cycle.

[pic]

• Types of malaria

o The disease presentation will vary according to patient’s state of

immunity, the intensity of the infection and the presence of

accompany conditions such as malnutrition, anaemia and other

diseases.

▪ Uncomplicated Malaria
• Uncomplicated malaria is defined as symptomatic malaria

without signs of severity or evidence (clinical or

laboratory) of vital organ dysfunction.

• In this type of malaria, symptoms are present, but there

are no signs to indicate severe infection or dysfunction of

the vital organs.

• This form can become severe malaria if left untreated, or

if the host has poor or no immunity.

▪ Severe Malaria
• Severe malaria is symptomatic malaria with signs of

severity of vial organ dysfunction. Severe Plasmodium

falciparum malaria is a medical emergency.

• In severe malaria, clinical or laboratory evidence shows

signs of vital organ dysfunction

• Delay in diagnosis and provision of appropriate treatment

may lead to serious complications and even death

Signs and Symptoms

• Signs and symptoms of uncomplicated malaria

o Fever, headache, nausea, vomiting,

o Malaise, fatigue, muscle pain,

o Anorexia, chill, rigors, sweats, cough and diarrhea

• Signs and symptoms of severe malaria

o Fever and chills

o Impaired consciousness

o Change in behavior

o Prostration/extreme weakness

o Respiratory distress

o Circulatory collapse/shock

o Vomiting everything

o Multiple convulsions

o Deep breathing and respiratory distress

o Abnormal bleeding and signs of anemia

o Clinical jaundice and evidence of vital organ dysfunction

o Severe malaria can be fatal without treatment

o Inability to drink or breastfeed

o Complications of severe malaria include;

▪ Hyperpyrexia, convulsions, shock, hypoglycaemia, metabolic

acidosis, acute renal failure or pulmonary oedema

o In Tanzania the commonest presentations of severe malaria are;

▪ Severe anaemia
▪ Coma (cerebral Malaria)

Treatment and Prevention

• Treatment of Uncomplicated Malaria

o Artemisinin-based combination therapy (ACT) is recommended by the

WHO to treat uncomplicated malaria.

o ACT is artemisinin combined with a partner drug. The role of

artemisinin is to reduce the number of parasites within the first 3

days of infection, while the partner drugs eliminate the rest.

o These drugs include;

▪ Artemether-Lumefanthrine
▪ Dihydroartemisinin with Piperaquine
▪ Uncomplicated malaria in first trimester of pregnancy is

managed by quinine tablet

• Treatment of Severe Malaria

o Hypoglycaemia is the major problem in the management of severe

malaria especially in young children and pregnant women.

Hypoglycaemia should be looked and treated accordingly. Other

features like anaemia should also be addressed

▪ Medications include:
• Quinine injection
• Artesunate injection

|Activity: Take home Assignment (10 minutes) |

| |

|DIVIDE students in groups or individual. |

| |

|ASK the students to work on the following assignment |

| |

|Explain the dose and dosing schedule for antimalarial drugs used in |

|the treatment of uncomplicated and severe malaria in Tanzania |

| |

|ALLOCATE time for students to do the assignment and submit |

| |

|REFER students to recommended references |

• Prevention of Malaria

|Activity: Buzzing (5 minutes) |

| |

|ASK students to pair up and buzz on the following question for 2 |

|minutes |

| |

|How is malaria prevented? |

| |

|ALLOW few pairs to respond and let other pairs to add on points |

|not mentioned |

| |

|WRITE their response on the flip chart/board |

| |

|CLARIFY and SUMMARIZE by using the content below |

• Malaria is prevented through;

o Clearing of bushes around houses to destroy mosquito breeding sites

o Sleeping under insecticide-treated mosquito nets to avoid bites when

sleeping

o Using mosquito repellents

o Prevention of malaria in pregnancy (Intermittent preventive

treatment in pregnancy (IPTp))

▪ Through using antimalaria drugs to prevent transmission of

malaria from pregnant women to the foetus

• Sulphadoxine/Pyrimethamine (SP)
• The first IPTp dose is administered between 20-24 weeks of

gestational age and the second IPTp dose at 28 – 32 weeks

STEP 3: Toxoplasmosis (35 minutes)

Cause and Transmission

• Toxoplasmosis is a zoonotic disease which is caused by coccidian protoan

Toxoplama gondii. Toxoplasmosis is a disease of blood and lymphatic

system

• The parasite infects a wide range of animals, birds but does not appear

to cause disease in them.

• The only known definitive hosts for Toxoplasma gondii are members of

family Felidae (domestic cats and their relatives

• T. gondii is transmitted through;

o Consumption of undercooked contaminated meat of animals harboring

tissue cysts

o Consuming food or water contaminated with cat feces

o Exposure to contaminated environmental samples (such as fecal-

contaminated soil or changing the litter box of a pet cat)

o Blood transfusion or organ transplantation

o Transplacentally from mother to fetus

▪ The damage to the unborn child is often more severe the

earlier in pregnancy the transmission occurs. Potential results

can be

▪ a miscarriage
▪ a stillborn child
▪ a child born with signs of toxoplasmosis (e.g., abnormal

enlargement or smallness of the head)

• Life cycle of Toxoplama gondii

o Unsporulated oocysts are shed in the cat’s feces

o Oocysts take 1-5 days to sporulate in the environment and become

infective.

o Intermediate hosts in nature (including birds and rodents) become

infected after ingesting soil, water or plant material contaminated

with oocysts

o Oocysts transform into tachyzoites shortly after ingestion.

o These tachyzoites localize in neural and muscle tissue and develop

into tissue cyst bradyzoites

o Cats become infected after consuming intermediate hosts harboring

tissue cysts or directly by ingestion of sporulated oocysts

o Animals bred for human consumption and wild game may also become

infected with tissue cysts after ingestion of sporulated oocysts in

the environment

o In the human host, the parasites form tissue cysts, most commonly in

skeletal muscle, myocardium, brain, and eyes; these cysts may remain

throughout the life of the host

[pic]

Signs and Symptoms

• Most healthy people do show signs or symptoms
• Signs and symptoms mimic those of flu, including:

o Body aches

o Swollen lymph nodes

o Headache

o Fever

o Fatigue

• In compromised immunity e.g. in HIV/AIDS, more severe signs and symptoms

may develop;

o Headache

o Confusion

o Poor coordination

o Seizures

o Lung problems that may resemble tuberculosis or Pneumocystis

jiroveci pneumonia, a common opportunistic infection that occurs in

people with AIDS

o Blurred vision caused by severe inflammation of your retina (ocular

toxoplasmosis)

Treatment and Prevention

• Toxoplasmosis is treated by both supportive and pharmacological therapy
• Medications include;

o Sulphadiazine

o Pyrimethamine

o Folic acid

o Clindamycin

• Preventive measures include;

o Personal hygiene e.g. washing hands after contact with cat

o Avoiding exposure to cat faeces

STEP 4: African Trypanosomiasis (30 minutes)

Cause and Transmission

• African Trypanosomiasis, also known as “sleeping sickness,” is caused by

microscopic parasites (Trypanosmes) of the Trypanosoma brucei complex

• Trypanosomes are a group of flagellated (one flagellum) protozoa

belonging to the genus Trypanosomes in the family Trypanosomatidae.

• Adult trypanosomes are mainly blood parasites of vertebrates (a

mammalian host) and require an intermediate (insect) host (usually an

insect) to complete their life cycle

o Trypanosome undergoes complex changes during its life cycle to

facilitate survival in the insect gut and the mammalia bloodstream.

• Two sub-species of Trypanosoma brucei cause African Trypanosomiasis in

humans

▪ Trypanosome brucei gambiense
▪ Trypanosome brucei rhodesiense
• Humans are the main reservoir for Trypanosoma brucei gambiense, but this

species can also be found in animals. Wild game animals and cattle are

the main reservoir of T. b. rhodesiense.

• Trypanosomiasis is transmitted by tsetse fliles of the Glossina species

o Other modes of transmission are possible.

▪ Mother to child infection across placenta
▪ Blood transfusion (of infected blood)
• The disease is found in two forms depending on the parasite;

o T.b. gambense is found in Central and Western Africa

▪ The disease is chronic and extends in a passive phase for

months or years before symptoms emerge

o T.b. rhodesiense is found in Southern and Eastern Africa

▪ The disease is acute but more limited
▪ Infection emerges in a few weeks and is more virulent and

faster developing

• Life cycle of Trypanosoma brucei

o During a blood meal on the mammalian host, an infected tsetse fly

(genus Glossina) injects metacyclic trypomastigotes into skin

tissue.

o The parasites enter the lymphatic system and pass into the

bloodstream.

o Inside the host, they transform into bloodstream trypomastigotes,

are carried to other sites throughout the body, reach other blood

fluids (e.g. lymph, spinal fluid), and continue the replication by

binary fission

o The entire life cycle of African Trypanosomes is represented by

extracellular stages.

o The tsetse fly becomes infected with bloodstream trypomastigotes

when taking a blood meal on an infected mammalian host

o In the tsetse fly’s midgut, the parasites transform into procyclic

trypomastigotes, multiply by binary fission, leave the midgut, and

transform into epimastigotes

o The epimastigotes reach the fly’s salivary glands and continue

multiplication by binary fission

o The cycle in the fly takes approximately 3 weeks

[pic]

• The clinical course of human African trypanosomiasis has two stages.

o In the first stage, the parasite is found in the peripheral

circulation, but it has not yet invaded the central nervous system.

o In the second stage, the parasite crosses the blood-brain barrier

and infects the central nervous system

• The subspecies that cause African trypanosomiasis have different rates

of disease progression, and the clinical features depend on which form

of the parasite (T. b. rhodesiense or T. b. gambiense) is causing the

infection. However, infection with either form will eventually lead to

coma and death if not treated.

Signs and Symptoms

• Following the bite of the infected fly (both male and female can

transmit infection), the parasite multiplies in the lymph and the blood

of the person bitten

• Unspecific symptoms and signs occurs

o Headaches, fever, weakness, pain in the joints, lymphadenopathy

(Winterbottom’s sign), and stiffness.

o People who become infected may or may not show signs of illness

immediately, but over time the parasite crosses the blood-brain

barrier and migrates to the central nervous system.

▪ Various neurological changes which include;
• Sleep disorder
• Deep sensory disturbances
• Abnormal tone and mobility
• Ataxia
• Psychiatric disorders
• Seizures
• Coma and ultimately death.

Treatment

• Sleeping sickness is difficult to treat considering the toxicity and

complex administration of the drugs currently available for treatment.

• Furthermore, parasite resistance to existing drugs is always a risk.
• Medications used in treatment African trypanosomiasis

o Pentamidine (for T.b. gambianse)

o Suramin (T.b. rhodesiense)

o Melarsoprol

o Eflornithine

o Nifurtimox (is used in combination under special authorizations)

o Pentamidine and suramin are used in the first or early stage of

T.b.gambiense and T.b. rhodesiense infections respectively.

|Activity: Take home Assignment (10 minutes) |

| |

|DIVIDE students in groups or individual. |

| |

|ASK the students to work on the following assignment |

| |

|Prepare a presentation on the doses and dose schedules for medicines |

|used in the treatment of African trypanosomiasis in Tanzania. |

| |

|ALLOCATE time for students to do the assignment and submit |

| |

|REFER students to recommended references |

Prevention

• Preventive measures are aimed at minimizing contact with tsetse flies.

o Protection against bites by tsetse flies

▪ Wearing of long-sleeved shirts and pants of medium-weight

material in neutral colours that blend with the background

environment. (Tsetse flies are attracted to bright or dark

colours, and they can bite through lightweight clothing)

▪ Using insect repellents
▪ Inspect vehicles before entering. The flies are attracted to

the motion and dust from moving vehicles.

o Case finding and early treatment

o Vector control

STEP 5: Key Points (5 minutes)

• African Trypanosomiasis is caused by microscopic parasites

(Trypanosomes) of the Trypanosoma brucei complex that are transmitted by

Typanosoma brucei gambiense and Trypanosoma brucei rhodesiense

• Trypanosomes are a group of flagellated (one flagellum) protozoa

belonging to the genus Trypanosomes

• The subspecies that cause African trypanosomiasis have different rates

of disease progression, and the clinical features depend on which form

of the parasite (T. b. rhodesiense or T. b. gambiense) is causing the

infection. Both infections eventually lead to coma and death if not

treated.

STEP 6: Evaluation (5 minutes)

• How is African trypanosomiasis transmitted?
• How is African trypanosomiasis prevented?
• What are the organisms that cause African trypanosomiasis?

References

Hugo and Russell (2011), Pharmaceutical Microbiology 8th Edition, Willey-

Blackwel publications

Karen C. Carroll et al (2013); Jawetz, Melnick and Adelberg’s Medical

Microbiology 26th Ed. McGraw Hill Co. Inc.

Greenwood et al (2012); Medical Microbiology, 18th edition Churchill

Livingstone

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top